Posterior reversible encephalopathy syndrome

Current Opinion in Ophthalmology

Volumn 19, Issue 6, 2008, Pages 479-484

  Pula, John H ^a   Eggenberger, Eric ^a  

^a East Lansing   (United States)

Author keywords

Eclampsia; Hypertensive encephalopathy; Posterior reversible encephalopathy; Posterior reversible encephalopathy syndrome; Posterior reversible leukoencephalopathy; Reversible posterior leukoencephalopathy

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOSPORIN; DEXAMETHASONE; DIAZEPAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETIRACETAM; FOSPHENYTOIN SODIUM; GLYCERYL TRINITRATE; HYDRALAZINE; IMMUNOSUPPRESSIVE AGENT; LABETALOL; LORAZEPAM; MAGNESIUM SULFATE; METHYLPREDNISOLONE; NICARDIPINE; OXYBUTYNIN; PHENYTOIN; VALPROIC ACID;

ABSENCE OF SIDE EFFECTS; AUTOREGULATION; BRAIN CORTEX; BRAIN EDEMA; BRAIN STEM; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CLINICAL FEATURE; CONFUSION; ECLAMPSIA; GRAY MATTER; HEADACHE; HUMAN; HYPERTENSION; LEUKOENCEPHALOPATHY; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEIZURE; SPINAL CORD; VISUAL IMPAIRMENT;

ACUTE DISEASE; AUTOIMMUNE DISEASES; ECLAMPSIA; FEMALE; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; INFECTION; MAGNETIC RESONANCE IMAGING; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; PREGNANCY; RISK FACTORS;

EID: 56249114158     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e3283129746     Document Type: Review

References (58)

1. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephatopathy syndrome. N Engl J Med 1996; 334:494-500.
2. McGregor E, Isles C, Jay J. Retinal changes in malignant hypertension. Br Med J (Clin Res Ed) 1986; 292:233-234.
3. Liebowte H, Hall P. Cortical blindness as a complication of eclampsia. Ann Emergency Med 1984; 13:365-367.
4. Marra T, Shah M, Mikus M. Transient cortical blindness due to hypertensive encephalopathy: magnetic resonance imaging correlation. J Clin Neuroophthalmol 1993; 13:35-37.
5. Sibia B, Dekker G, Kupferminc M. Preeclampsia. Lancet 2005; 365785-799.
6. Schwartz RB, Johns KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR Imaging, and SPECT imaging in 14 cases. AJR 1992; 159:379-383.
7. Schwartz RB. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:1743-1746.
8. Pavlakis SG, Frank Y, Kalina P, et al. Occipital-parietal encephalopathy: a new name for an old syndrome. Pediatr Neural 1997; 16:145-148.
9. Narbone MC, Musolino R, Granata F, et al. PRES: posterior or potentially reversible encephalopathy syndrome? Neural Sci 2006; 27:187-189.
10. Hinchey J, Caplan LR, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:1743-1746.
11. Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. ANJR Am J Neuroradiol 2007; 28:1320-1327. Review concluding that three common imaging patterns occur in PRES, expanding the previous concept that the disease affects only the posterior cerebrum.
12. Belfort MA, Varner MW, Dizon-Townson DS, et al. Cerebral perfusion pressure, and not cerebral blood flow, may be the critical determinant of intracranial injury in preeclampsia: a new hypothesis. Am J Obstet Gynecol 2002; 187:626-634.
13. Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008; 29:1043-1049. Suggests that vasoconstriction may have an influence on the development of edema in PRES.
14. Brubaker LM, Smith JK, Lee YZ, et al. Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR Imaging. AJNR Am J Neuroradiol 2005; 26:825-830.
15. Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008; 29:1036-1042. A review of the pertinent features of the disease.
16. Doelken M, Lanz S, Rennert J, et al. Differentiation of cytotoxic and vasogenic edema in a patient with reversible posterior leukoencephalopathy syndrome using diffusion-weighted MRI. Diagn Interv Radiol 2007; 13:125-128. Restricted diffusion on MRI can help distinguish ischemia from the vasogenic edema typically seen in PRES.
17. Haubrich C, Wendt A, Diehl RR, Klötzsch C. Dynamic autoregulation testing in the posterior cerebral artery. Stroke 2004; 35:848-852.
18. Schwartz RB, Feske SK, Polak JF, et al. Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 2000; 217:371-376.
19. Chou WH, Messing RO. Hypertensive encephalopathy and the blood-brain barrier: is δPKC a gatekeeper? J Clin Invest 2008; 118:17-20. Future treatments of PRES or other syndromes involving vasogenic edema may target the blood-brain barrier directly.
20. Bartynski WS, Tan HP, Boardman JF, et al. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol 2008; 29:924-930. The characteristics of PRES in this population are examined.
21. Bartynski WS, Boardman JF, Zeigler ZR, et al. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 2006; 27:2179-2190.
22. Leroux G, Sellam J, Costedoat-Chalumeau N, et al. Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus 2008; 17:139-147. Study indicating that other comorbid predisposing factors of PRES usually exist in patients with lupus who develop PRES.
23. Gocmen R, Ozgen B, Oguz KK. Widening the spectrum of PRES: series from a tertiary care center. Eur J Radiol 2007; 62:454-459.
24. Striano P, Striano S, Tortora F, et al. Clinical spectrum and critical care management of posterior reversible encephalopathy syndrome (PRES). Med Sci Monit 2005; 11:CR549-CR553.
25. Ozkan A, Hakyemez B, Ozkalemkas F, et al. Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy. Neuroradiology 2006; 48:887-892.
26. Kurahashi H, Okumura A, Koide T, et al. Posterior reversible encephalopathy syndrome in a child with bronchial asthma. Brain Dev 2006; 28:544-546.
27. Poon WL, Mok CC. Reversible posterior leukoencephalopathy in scleroderma. Ann Rheum Dis 2005; 64:1803-1804.
28. Mellion ML, Rizvi S. Spontaneous bilateral carotid artery dissection and posterior reversible encephalopathy syndrome. Neurology 2005; 65:1990.
29. Irvin W, MacDonald G, Smith JK, Kim WY. Dexamethasone-induced posterior reversible encephalopathy syndrome. J Clin Oncol 2007; 25:2484-2486.
30. Kastrup O, Maschke M, Wanke I, Diener HC. Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol 2002; 249:563-1566.
31. Finsterer J, Schlager T, Kopsa W, Wild E. Nitroglycerin-aggravated preeclamptic posterior reversible encephalopathy syndrome (PRES). Neurology 2003; 61:715-716.
32. Legriel S, Bruneel F, Spreux-Varoquaux O, et al. Lysergic acid amid-induced posterior reversible encephalopathy syndrome with status epilepticus. Neurocrit Care 2008 Apr 30. [Epub ahead of print] Case study of an uncommon association with PRES.
33. Seet R, Lim E. Hypertensive brainstem encephalopathy. Circulation 2007; 115:e310-e311.
34. Williams LR, Darragh RK, Sokol DK, et al. Reversible posterior leukoencephalopathy syndrome associated with left ventricular assist device. Transplant Proc 2005; 37:4513-4514.
35. Morris EB, Laningham FH, Sandlund JT, Khan RB. Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer 2007; 48:152-159.
36. Onder AM, Lopez R, Teomete U, et al. Posterior reversible encephalopathy syndrome in the pediatric renal population. Pediatr Nephrol 2007; 22:1921-1929. Review of the clinical features and natural history of PRES in pediatric patients with kidney transplant and renal disease.
37. Punaro M, Abou-Jaoude P, Cimaz R, Ranchin B. Unusual neurologic manifestations (II): posterior reversible encephalopathy syndrome (PRES) in the context of juvenile systemic lupus erythematosus. Lupus 2007; 16:576-579.
38. Wirrel EC, Hamiwka LD, Hamiwka LA, et al. Acute glomerulonephritis presenting with PRES: a report of 4 cases. Can J Neurol Sci 2007; 34:316-321. Case series associating PRES with this population.
39. Branson JA, Dale RC. Transient bilateral blindness and posterior reversible encephalopathy syndrome: a rare complication of enuresis treatment. J Paediatr Child Health 2008; 44:380-382. An association of anticholinergic therapy with PRES.
40. McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR 2007; 189:904-912. Review of 76 cases of PRES that analyzes the clinical and radiographic features of the disease.
41. Kozak OS, Wijdicks EFM, Manno EM, et al. Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 2007; 69:894-897. Convulsive or nonconvulsive status of the epilepticus may be the presenting feature of PRES.
42. Bakker RC, Verburgh CA, Buchem MA, Paul LC. Hypertension, cerebral oedema and fundoscopy. Nephrol Dial Transplant 2003; 18:2424-2427.
43. Albini TA, Lakhanpal RR, Foroozan R, et al. Retinopathy and choroidopathy as the initial signs of hypertensive brainstem encephalopathy. Arch Ophthalmol 2006; 124:1784-1785.
44. Gibson P, Carson MP. Hypertension in pregnancy. In: Letterie GS, Talavera F, Gaupp FB, Smith CV, editors. Emedicine: hypertension and pregnancy [Last updated 13 December 2007]. http://www.emedicine.com/MED/topic3250.htm.
45. Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR Imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 2000; 21:1199-1206.
46. Fujiwara H, Momoshima S, Kuribayashi S, Sasamura H. Hypertensive encephalopathy of brain stem with minimal supratentorial involvement: a rare manifestation of hypertensive encephalopathy. Radiat Med 2005; 23:504-507.
47. McCarron MO, McKinstry CS. Vanishing brainstem edema. J Stroke Cerebrovasc Dis 2008; 17:156-157. Case report of brainstem involvement as the major manifestation of PRES.
48. Lim MH, Kim DW, Cho HS, et al. Isolated cerebellar reversible leukoencephalopathy syndrome in a patient with end stage renal disease. Intern Med 2008; 47:43-45. Case report of isolated cerebellar involvement as the major manifestation of PRES.
49. Milia A, Moller J, Pilia G, et al. Spinal cord involvement during hypertensive encephalopathy: clinical and radiological findings. J Neurol 2008; 255:142-143. Case report suggesting that PRES can be associated with spinal cord involvement.
50. Tateishi Y, Iguchi Y, Kimura K, et al. A case of autoimmune thyroid disease presenting posterior reversible encephalopathy syndrome. J Neurol Sci 2008; 271:203-206. Case study showing that PRES associated with autoimmune thyroid disease can be clinically and radiologically reversible with treatment.
51. Choudhary M, Rose F. Posterior reversible encephalopathy syndrome due to severe hypercalcemia in AIDS. Scand J Infect Dis 2005; 37:6524-6526.
52. Saeed B, Abou-Zor N, Amer Z, et al. Cyclosporin-A induced posterior reversible encephalopathy syndrome. Saudi J Kidney Dis Transpl 2008; 19:439-442. Case report in which visual impairment due to PRES persists despite treatment
53. Sweany JM, Bartynski WS, Boardman JF. 'Recurrent' posterior reversible encephalopathy syndrome: report of 3 cases - PRES can strike twice! J Comput Assist Tomogr 2007; 31:148-156.
54. Lipstein H, Lee CC, Crupi RS. A current concept of eclampsia. Am J Emerg Med 2003; 21:223-226.
55. Setvillo G, Striano P, Striano S, et al. Posterior reversible encephatopathy syndrome (PRES) in critically ill obstetric patients. Intensive Care Med 2003; 29:2323-2326.
56. Elliott WJ. Clinical features in the management of selected hypertensive emergencies. Prog Cardiovasc Dis 2006; 48:316-325.
57. Aggarwal M, Khan IA. Hypertensive crisis: hypertensive emergencies and urgencies. Cardiol Clin 2006; 24:135-146.
58. Mak A, Chan BPL, Yeh IB, et al. Neuropsychiatric lupus and reversible posterior leukoencephalopathy syndrome: a challenging clinical dilemma. Rheumatology 2008; 47:256-262. PRES in the setting of lupus may be confused with other causes of lupus cerebritis.